Lymphatica Medtech | Raises seven-digit Series A round
Summary
The investment round was led by the High Tech Gr\xfcnderfonds, a large and experienced German VC fund that will accompany them on their way forward. The EIT Health contributed to the financement, funding development activities to improve the usability and digitalisation of its product, LymphoDRAIN. The funds will be used to advance in the roadmap to bring LymphoDRAIN to lymphedema patients.LYMPHATICA Medtech SA is a Swiss medical device company founded in July 2017. The Company vision is to become the leader in the development and marketing of innovative medical devices for the treatment of lymphatic diseases. LYMPHATICA has been supported by a number of institutions and programs, including the European Commission (EIC pilot), Innosuisse (Swiss Innovation Agency), FIT (Foundation for Technological Innovation), Canton Vaud (SPEI), VentureKick, Venture Leaders, MassChallenge (Gold Award) and >>venture>> (Business Plan Award).